Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Radiation-induced hair loss may be caused by hair growth stopping and inflammation in blood vessels.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

The mystacial pad's innervation in adult rats is more complex than previously thought.

Dual wavelength LED caps can safely increase hair density in androgenetic alopecia.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

A new method effectively predicts estrogen-related health effects for early screening.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.